TG THERAPEUTICS, INC.

NEW YORK, NY How do I update this listing?

TG Therapeutics is based out of New York. Whalewisdom has at least 67 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-03-26. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Email Alert

Contact Info

tg therapeutics, inc.
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK NY    10014

Business Phone: (212) 554-4484
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2012-03-26 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 25,000,000 11,091,426 13,908,574
2012-02-29 D/A PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 25,000,000 25,000,000 0
2012-02-22 D/A PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 25,000,000 20,875,405 4,124,595
2010-03-16 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 4,000,000 2,547,500 1,452,500
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
DOUGLAS ABEL subscription required
    DIRECTOR
MICHAEL MCGUINNESS subscription required
    EXECUTIVE OFFICER
MICHAEL WEISS subscription required
    EXECUTIVE OFFICER DIRECTOR
NEIL HERSKOWITZ subscription required
    DIRECTOR
RICHARD STEINHART subscription required
    DIRECTOR
SEAN POWER subscription required
    EXECUTIVE OFFICER
TIMOTHY MCINERNEY subscription required
    DIRECTOR

Elevate your investments